Literature DB >> 6260987

Replication of parvoviral DNA. I. Characterization of a nuclear lysate system.

C Pritchard, E R Stout, R C Bates.   

Abstract

We have developed a nuclear lysate system from infected, synchronized cells capable of synthesizing unit-length parvoviral DNA in vitro. It was necessary to supplement the nuclear lysates with the polyamines, spermidine and spermine, to prevent degradation of template and product DNAs. In this system RF, RI, and single-stranded progeny DNAs were synthesized. Label incorporated in viral RF DNA in vivo appeared first in RI DNA and then in single-stranded DNA during incubation in vitro. By sedimentation the product DNAs were identical to those found in infected cells. Their viral identity was confirmed by hybridization. The addition of ribonucleotides, RNase, or alpha-amanitin did not affect parvoviral DNA synthesis in this system. The results with the specific inhibitors of mammalian DNA polymerases, aphidicolin, N-ethylmaleimide, and 2',3'-dideoxythymidine 5'-triphosphate indicated that DNA polymerase alpha was required for synthesis of parvoviral DNA in the nuclear lysates. This requirement was confirmed by experiments with antibody to bovine DNA polymerase alpha.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260987      PMCID: PMC171013     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Vertebrate DNA polymerases.

Authors:  A Weissbach
Journal:  Cell       Date:  1975-06       Impact factor: 41.582

2.  Hydroxyurea synchoronization of bovine fetal spleen cells.

Authors:  D S Parris; R C Bates; E R Stout
Journal:  Exp Cell Res       Date:  1975-12       Impact factor: 3.905

3.  Complementation of the temperature-sensitive defect in H5ts125 adenovirus DNA replication in vitro.

Authors:  L M Kaplan; H Ariga; J Hurwitz; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Involvement of DNA polymerase alpha in simian virus 40 DNA replication.

Authors:  H J Edenberg; S Anderson; M L DePamphilis
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

5.  Synthesis of viral and host DNA in isolated chromatin from herpes simplex virus-infected HeLa cells.

Authors:  M Yamada; G Brun; A Weissbach
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

6.  The multiplication of parvovirus Lu3 in a synchronized culture system. I. Optimum conditions for virus replication.

Authors:  G Siegl; M Gautschi
Journal:  Arch Gesamte Virusforsch       Date:  1973

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  Self-complementarity of terminal sequences within plus or minus strands of adenovirus-associated virus DNA.

Authors:  F J Koczot; B J Carter; C F Garon; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha.

Authors:  S Ikegami; T Taguchi; M Ohashi; M Oguro; H Nagano; Y Mano
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

10.  Adenovirus DNA replication in vitro.

Authors:  M D Challberg; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

View more
  3 in total

Review 1.  DNA polymerases in prokaryotes and eukaryotes: mode of action and biological implications.

Authors:  U Hübscher
Journal:  Experientia       Date:  1983-01-15

2.  In vitro conversion of MVM parvovirus single-stranded DNA to the replicative form by DNA polymerase alpha from Ehrlich ascites tumour cells.

Authors:  E A Faust; C D Rankin
Journal:  Nucleic Acids Res       Date:  1982-07-24       Impact factor: 16.971

3.  Adeno-associated virus vectors preferentially transduce cells in S phase.

Authors:  D W Russell; A D Miller; I E Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.